August 30, 2015 | The Israel-based venture capital firm and incubator Trendlines Group has opened a branch in Singapore. Trendlines hopes to help Singaporean medical technology companies develop their product for commercialization in larger markets, like the United States and China. In addition, there are reports that Trendlines Group is interested in issuing an initial public offering on a Singapore Exchange in November, which would value the company at between $80-$100 million. Trendlines Group was founded in 2007 and has about 50 startups in its portfolio of medical and agricultural technology companies.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israel Invests Millions To Help AI Comprehend Hebrew, Arabic
September 21, 2023

Cybersecurity Startup Cato Raises $238M With $3B Valuation
September 21, 2023

Israel, UK Ink Deal For Greater Innovation Collaboration
September 21, 2023

ALS Drug Receives Patent In Israel, Europe, Japan
September 20, 2023
Facebook comments